Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 1l2j | ETC | Estrogen receptor beta |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 1l2j | ETC | Estrogen receptor beta | / | 1.000 | |
| 1og5 | SWF | Cytochrome P450 2C9 | / | 0.482 | |
| 1mkd | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.457 | |
| 3cv9 | VDX | Vitamin D3 dihydroxylase | / | 0.452 | |
| 2vn0 | TDZ | Cytochrome P450 2C8 | / | 0.450 | |
| 2y46 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.445 | |
| 1bvr | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.442 | |
| 4o71 | CPB | Bromodomain-containing protein 4 | / | 0.441 | |
| 4r20 | AER | Cytochrome P450 family 17 polypeptide 2 | / | 0.441 | |
| 4b4o | NDP | Epimerase family protein SDR39U1 | / | 0.440 |